This is supported by previous studies showing a correlation between disease activity and serum TNF-α and adiponectin levels in children and adult biopsy-proven NAFLD patients warranting inflammation and oxidative stress as viable therapeutic targets of NASH [62,63,64]. Here, TNF is linked to metabolic dysfunction-associated steatohepatitis.